Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
clinical trials
detroit blog main
5
×
detroit top stories
fda
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer immunotherapy
drugs
investing
nonalcoholic steatohepatitis
startups
abbvie
astrazeneca
bristol-myers squibb
crispr therapeutics
deals
What
drug
5
×
cancer
fda
roundup
annual
approved
attention
bio
biotech
medicine
ahead
alzheimer’s
ambien
american
asco
assessed
attendees
camp’s
cash
chicago
city
clinical
combinations
communities
community’s
companies
conference
days
deeper
digital
disease
dna
eisai
epidemic
esmo
europe
expanding
fatty
fingerprint
flags
Language
unset
Current search:
fda
×
drug
×
" detroit blog main "
×
cancer
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More